Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
Aim. To assess the effectiveness of a selective I1 imidazoline receptor agonist, rilmenidine, in women with Stage I arterial hypertension (AH), Type 2 diabetes mellitus (DM-2), and visceral obesity (VO), taking into account antihypertensive effects and dynamics of endothelial dysfunction (ED) bioche...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1565 |